ACM
CELG

Atika Capital Management’s Celgene Corp CELG Stock Holding History

Atika Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,500
Closed -$1.22M – 86
2015
Q2 		$1.22M Buy
+10,500
New +$1.2M 0.55% 56

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Atika Capital Management's CELG Position: Q1 2016 in Review

Atika Capital Management sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 3,000 shares — an estimated $359K sold.

Atika Capital Management first reported a position in CELG in Q3 2014 and held it in 4 quarters. The position peaked at $3.13M in Q3 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Atika Capital Management reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • Atika Capital Management sold 3,000 Celgene Corp shares in Q1 2016, an estimated $359K.
  • Atika Capital Management first reported a position in Celgene Corp in Q3 2014 and held it in 4 quarters.
  • Atika Capital Management's Celgene Corp position peaked at $3.13M in Q3 2014.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.